MiMedx's AmnioFix Injectable meets in Phase IIb for plantar fasciitis

MiMedx Group Inc. (NASDAQ:MDXG) reported top-line data from the single-blind, U.S. Phase IIb IND trial in 145

Read the full 176 word article

User Sign In